U.S. SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C.  20549

                                   FORM 10-QSB

     [  X  ]     QUARTERLY  REPORT  PURSUANT  TO  SECTION  13  OR  15(d)  OF THE
SECURITIES  EXCHANGE  ACT  OF  1934

     For  the  quarterly  period  ended  September  30,  2002

     [   ]     TRANSITION  REPORT  PURSUANT  TO  SECTION  13  OR  15(d)  OF  THE
SECURITIES  EXCHANGE  ACT  OF  1934

     For  the  transition  period  from     to

                          Commission File No. 333-85460

                          VIBRANT HEALTH INTERNATIONAL
        (Exact name of small business issuer as specified in its charter)

              NEVADA                                   84-1595734
        (State or other jurisdiction of       (IRS Employer Identification No.)
         incorporation  or organization)


                8907 E. CHENANGO AVE, GREENWOOD VILLAGE, CO 80111
                     (Address of principal executive offices)

                                  303-713-1870
                           (Issuer's telephone number)

                                 NOT APPLICABLE
      (Former name, address and fiscal year, if changed since last report)

Check  whether  the  issuer  (1)  has  filed all reports required to be filed by
Section  13  or 15(d) of the Exchange Act during the preceding 12 months (or for
such  shorter period that the issuer was required to file such reports), and (2)
has been subject to such filing requirements for the past 90 days. Yes [ X] No [
]

APPLICABLE  ONLY  TO  ISSUERS  INVOLVED  IN  BANKRUPTCY  PROCEEDINGS  DURING THE
PRECEDING  FIVE  YEARS:

Check  whether the registrant has filed all documents and reports required to be
filed  by  Sections  12,  13,  or  15(d)  of  the Exchange Act subsequent to the
distribution  of  securities under a plan confirmed by a court. Yes [  ] No [  ]

APPLICABLE  ONLY  TO  CORPORATE  ISSUERS:

State the number of shares outstanding of each of the issuer's classes of common
equity,  as  of  September 30, 2002: 3,935,000 shares of common stock, par value
$.001

Transitional  Small  Business  Format:  Yes  [   ]  No  [  X  ]


<PAGE>

<TABLE>
<CAPTION>

                                  FORM 10-QSB
                          VIBRANT HEALTH INTERNATIONAL
                          (A Development Stage Company)
                                      INDEX

                                                                                   Page
<S>       <C>                                                                      <C>
PART I..  Financial Information

          Item 1.  Financial Statements                                               3

          Consolidated Balance Sheets, September 30, 2002 (unaudited) and
          December 31, 2001                                                           4

          Unaudited Consolidated Statements of Operations for the Three Months
          and Nine Months ended September 30, 2002 and 2001 and cumulative from
          December 3, 1997 (Inception) through September 30, 2002                     5

          Unaudited Consolidated Statement of Stockholders Deficit for the
          period from December 3, 1997 (Inception) through September 30, 2002         6

          Unaudited Consolidated Statements of Cash Flows, for the Nine Months
          ended September 30, 2002 and 2001and cumulative from  December 3,
          1997 (Inception) through September 30, 2002.                                7

          Notes to Unaudited Consolidated Financial Statements                        8

          Item 2.  Management's Discussion and Analysis of Financial Condition or
          Plan of Operation                                                           9

          Item 3.     Controls and Procedures                                        11

PART II.  Other Information

          Item 2.  Changes in Securities and Use of Proceeds                         11

          Item 6.  Exhibits and Reports on Form 8-K                                  11

          Signatures                                                                 13
</TABLE>

(Inapplicable  items  have  been  omitted)

                                        2
<PAGE>

PART  I.

FINANCIAL  INFORMATION

Item  1.  Financial  Statements

In  the  opinion  of management, the accompanying unaudited financial statements
included  in this Form 10-QSB reflect all adjustments (consisting only of normal
recurring  accruals)  necessary  for  a  fair  presentation  of  the  results of
operations for the periods presented.  The results of operations for the periods
presented  are  not necessarily indicative of the results to be expected for the
full  year.


                                        3
<PAGE>

                  VIBRANT HEALTH INTERNATIONAL AND ITS WHOLLY OWNED SUBSIDIARY
                                 (A DEVELOPMENT STAGE COMPANY)

<TABLE>
<CAPTION>

                                   CONSOLIDATED BALANCE SHEET


                                                            September 30,    December 31, 2001
                                                                2002
                                                           ---------------
<S>                                                        <C>              <C>
  (unaudited)
ASSETS

Current assets
 Cash . . . . . . . . . . . . . . . . . . . . . . . . . .  $        7,520   $           23,009
  Accounts receivable . . . . . . . . . . . . . . . . . .             362                    -
                                                           ---------------  -------------------

Total assets. . . . . . . . . . . . . . . . . . . . . . .  $        7,882   $           23,009
                                                           ===============  ===================

LIABILITIES AND STOCKHOLDERS' DEFICIT
Current liabilities
 Accounts payable and accrued expenses. . . . . . . . . .  $       17,662   $            1,064
 Note payable . . . . . . . . . . . . . . . . . . . . . .          25,000               25,000
 Notes payable - related party. . . . . . . . . . . . . .          15,000               15,000
                                                           ---------------  -------------------
   Total current liabilities. . . . . . . . . . . . . . .          57,662               41,064
                                                           ---------------  -------------------

Commitments and contingencies

Stockholders' deficit
  Common stock, authorized 100,000,000 shares, $.001 par.           3,935                3,935
value; 3,935,000 shares issued and outstanding
  Additional paid-in capital. . . . . . . . . . . . . . .           4,035                4,035
  Deficit accumulated during the development stage. . . .         (57,750)             (26,025)
                                                           ---------------  -------------------
    Total stockholders' deficit . . . . . . . . . . . . .         (49,780)             (18,055)
                                                           ---------------  -------------------

Total liabilities and stockholders' deficit . . . . . . .  $        7,882   $           23,009
                                                           ===============  ===================
</TABLE>


                                        4
<PAGE>

                  VIBRANT HEALTH INTERNATIONAL AND ITS WHOLLY OWNED SUBSIDIARY
                                 (A DEVELOPMENT STAGE COMPANY)


<TABLE>
<CAPTION>


                           UNAUDITED CONSOLIDATED STATEMENTS OF OPERATIONS

                                                                                                    For the Period
                                                                                                   from December 3,
                                                                                                        1997
                                                     For the Three             For the Nine          (Inception)
                                                     Months Ended              Months Ended            through
                                                     September 30,             September 30,         September 30,
                                               ------------------------  ------------------------  ----------------
                                                  2002         2001         2002         2001         2002
                                               -----------  -----------  -----------  -----------  ---------
<S>                                            <C>          <C>          <C>          <C>          <C>

Sales . . . . . . . . . . . . . . . . . . . .  $   15,791   $        -   $   19,604   $        -   $ 19,933

Cost of goods sold. . . . . . . . . . . . . .       5,215            -        6,575            -      6,628
                                               -----------  -----------  -----------  -----------  ---------

Gross profit. . . . . . . . . . . . . . . . .      10,576            -       13,029            -     13,305
                                               -----------  -----------  -----------  -----------  ---------

Operating expenses
 Website development costs. . . . . . . . . .           -            -        2,209            -     12,209
 General and administrative expenses. . . . .      20,762        3,908       38,903        3,944     54,246
                                               -----------  -----------  -----------  -----------  ---------
   Total operating expenses . . . . . . . . .      20,762        3,908       41,112        3,944     66,455
                                               -----------  -----------  -----------  -----------  ---------

Loss from operations. . . . . . . . . . . . .     (10,186)      (3,908)     (28,083)      (3,944)   (53,150)

Interest expense. . . . . . . . . . . . . . .         842            -        3,642            -      4,808
                                               -----------  -----------  -----------  -----------  ----------

Net loss. . . . . . . . . . . . . . . . . . .  $  (11,028)  $   (3,908)  $  (31,725)  $   (3,944)  $(57,958)
                                               ===========  ===========  ===========  ===========  =========

Earnings (loss) per share - basic and diluted  $        -   $        -   $    (0.01)  $        -
                                               ===========  ===========  ===========  ===========

Weighted average shares outstanding . . . . .   3,935,000    3,688,152    3,935,000    3,238,535
                                               ===========  ===========  ===========  ===========
</TABLE>


                                        5
<PAGE>

                  VIBRANT HEALTH INTERNATIONAL AND ITS WHOLLY OWNED SUBSIDIARY
                               (A DEVELOPMENT STAGE COMPANY)

<TABLE>
<CAPTION>

                 UNAUDITED CONSOLIDATED STATEMENT OF STOCKHOLDERS' DEFICIT
        FOR THE PERIOD FROM DECEMBER 3, 1997 (INCEPTION) THROUGH SEPTEMBER 30, 2002

                                                                        Deficit
                                                                        Accumulated
                                                            Additional  During the     Total
                                           Common Stock     Paid-In     Development    Stockholders'
                                        ------------------
                                         Shares    Amount   Capital     Stage          Equity
                                        ---------  -------  ----------  -------------  ---------
<S>                                     <C>        <C>      <C>         <C>            <C>
Balance - December 3, 1997 (Inception)          -  $     -  $      -    $      -       $      -

Stock issued . . . . . . . . . . . . .    970,000      970         -           -            970

Net loss for periods . . . . . . . . .          -        -         -        (691)          (691)
                                        ---------  -------  ----------  -------------  ---------

Balance - December 31, 1999. . . . . .    970,000      970         -        (691)           279

Net loss . . . . . . . . . . . . . . .          -        -         -        (206)          (206)
                                        ---------  -------  ----------  -------------  ---------

Balance - December 31, 2000. . . . . .    970,000      970         -        (897)            73

Stock issued . . . . . . . . . . . . .  2,965,000    2,965     4,035           -          7,000

Net loss . . . . . . . . . . . . . . .          -        -         -     (25,128)       (25,128)
                                        ---------  -------  ----------  -------------  ---------

Balance - December 31, 2001. . . . . .  3,935,000    3,935     4,035     (26,025)       (18,055)

Net loss (unaudited) . . . . . . . . .          -        -         -     (31,725)       (31,933)
                                        ---------  -------  ----------  -------------  ---------

Balance - September 30, 2002 . . . . .  3,935,000  $ 3,935  $  4,035    $(57,750)      $(49,988)
                                        =========  =======  ========    =============  =========
</TABLE>


                                        6
<PAGE>

                VIBRANT HEALTH INTERNATIONAL AND ITS WHOLLY OWNED SUBSIDIARY
                             (A DEVELOPMENT STAGE COMPANY)

<TABLE>
<CAPTION>


                      UNAUDITED CONSOLIDATED STATEMENTS OF CASH FLOWS

                                                                          Cumulative
                                                                             from
                                                                          December 3,
                                                       For the Nine     1997 (Inception)
                                                      Months Ended            to
                                                       September 30,     September 30,
                                                   -------------------
                                                     2002       2001         2002
                                                   ---------  --------  ---------
<S>                                                <C>        <C>       <C>
Cash flows from operating activities
  Net loss. . . . . . . . . . . . . . . . . . . .  $(31,725)  $(3,944)  $(57,750)
  Adjustments to reconcile net loss to net cash
used in operating activities
    Common stock issued for interest expense. . .         -         -        750
     Changes in operating assets and liabilities
    Accounts receivable . . . . . . . . . . . . .      (362)        -       (362)
    Accounts payable and accrued expenses . . . .    16,598         -     17,662
                                                   ---------  --------  ---------
        Net cash used by operating activities . .   (15,489)   (3,944)   (39,700)
                                                   ---------  --------  ---------

Cash flows from financing activities
  Proceeds from note payable. . . . . . . . . . .         -         -     25,000
  Proceeds from notes payable - related party . .         -    15,000     15,000
  Proceeds from issuance of common stock. . . . .         -     1,000      7,220
                                                   ---------  --------  ---------
        Net cash provided by financing activities         -    16,000     47,220
                                                   ---------  --------  ---------

Net (decrease) increase in cash . . . . . . . . .   (15,489)   12,056      7,520

Cash, beginning of year . . . . . . . . . . . . .    23,009        73          -
                                                   ---------  --------  ---------

Cash, end of period . . . . . . . . . . . . . . .  $  7,520   $12,129   $  7,520
                                                   =========  ========  =========
</TABLE>


                                        7
<PAGE>

          VIBRANT HEALTH INTERNATIONAL AND ITS WHOLLY OWNED SUBSIDIARY
                          (A DEVELOPMENT STAGE COMPANY)

              NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS


NOTE  1  -  ORGANIZATION  AND  SUMMARY  OF  SIGNIFICANT  ACCOUNTING  POLICIES
-----------------------------------------------------------------------------

Vibrant  Health  International  (the  Company),  was formed on July 9, 2001 as a
Nevada  company.  The Company's business operations and contracts will primarily
be  conducted  by  its  wholly  owned  subsidiary,  Vibrant  Health,  Inc.

Vibrant  Health,  Inc.  was  formed  on  December 3, 1997 as a Colorado company.
Vibrant  Health,  Inc.  is  a supplier and distributor of health and nutritional
products via use of the Internet. Operations since inception consist principally
of  setting  up the Company, developing the Company's websites, and commencement
of  initial  product  sales.

On July 9, 2001, the Company issued 2,910,000 shares of common stock in exchange
for  100%  of  the  outstanding shares of Vibrant Health, Inc. Due to the common
ownership  of  the  companies,  the  acquisition  was  accounted  for  as  a
recapitalization  of  Vibrant  Health,  Inc.


NOTE  2  -  LIQUIDITY  AND  MANAGEMENT'S  PLANS
-----------------------------------------------

The  Company  has  incurred accumulated losses of approximately $58,000 from the
inception  of  Vibrant  Health  International  through September 30, 2002. These
losses  and  the  significant future cash requirements related to developing the
business  indicate substantial doubt that the Company may be able to continue as
a  going  concern  unless  additional  capital  is obtained or future profitable
operations  are  achieved.

During  2002, the Company completed a Form SB-2 Registration Statement under the
Securities  Act  of  1933.  The  offering  was  closed in October 2002 and total
proceeds of $106,400 were released to the Company from escrow.  Management feels
that with the resources that it now has currently available, the Company will be
able  to  maintain  its  operations  through  September  30,  2003.


                                        8
<PAGE>

ITEM  2.  MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION OR PLAN OF
OPERATION

FORWARD-LOOKING  STATEMENTS

Certain  information included in this report contains forward-looking statements
made  pursuant  to the Private Securities Litigation Reform Act of 1995 ("Reform
Act"). Such statements are based on current expectations and involve a number of
known  and  unknown  risks and uncertainties that could cause the actual results
and  performance  of  the  Company to differ materially from any expected future
results or performance, expressed or implied, by the forward-looking statements.
In connection with the safe harbor provisions of the reform act, the Company has
identified  important  factors  that  could  cause  actual  results  to  differ
materially  from such expectations, including operating uncertainty, acquisition
uncertainty,  uncertainties  relating  to  economic and political conditions and
uncertainties  regarding the impact of regulations, changes in government policy
and  competition.  Reference  is  made  to  all  of  the  Company's SEC filings,
including  the Company's Report on Form 10KSB, incorporated herein by reference,
for a description of certain risk factors. The Company assumes no responsibility
to  update  forward-looking  information  contained  herein.

GENERAL

We  were  incorporated in Nevada on July 9, 2001. We are a distributor of health
and  nutritional  products.  We have commenced only limited operations as of the
date  of  this filing. Currently, we are distributing healthcare products to our
customers  via  orders  generated  on  our  newly  functional Internet websites,
www.vibranthealthonline.com  and  www.store.yahoo.com/vibranthealthonline.  Our
current  business  operations  and  related  operational  contracts  are  being
conducted  out  of our wholly owned subsidiary, Vibrant Health, Inc., a Colorado
corporation.

We  distribute  health  and  nutritional products. We are a distribution company
only and do not have any expertise in nutritional science or manufacturing.  The
name  Vibrant  Health  does not reflect health expertise but rather is marketing
oriented  and  was  selected  to  instill  in  our customers a feeling of vigor,
energy,  and  motivation, with the obvious clarifying word of health pinpointing
our  product  focus.  We  believe  that  individuals  with  such  feelings  will
understand  the  value  of  fitness  and  appreciate  the value of our products.

We  are  to focusing our initial marketing efforts in generating sales orders by
using  our  Internet  websites.   We  will accept ancillary orders when they are
available to us by facsimile, email, phone calls, or mail.  However, our printed
material  will  generally  advocate  and  guide  the potential customer to route
orders for our product via our websites.  Although our websites are operational,
we  believe  our  websites  will  continuously  be  updated  and  refined.

We  do  not  manufacture  the  products that we sell.  Instead, we contract with
health and nutritional product formulators who specialize in supplying products.
Our  plan  as order volume increases will be to out-source our order fulfillment
operations  so  that  we  can  focus  on  the  marketing  sale  of our products.

We  have  entered  into  a  five-year  agreement  that expires October 2006 with
Imagenetix,  Inc.  a  company  located in southern California, to supply us with
their  proprietary  products.  They  have  experience in packaging and supplying
health  and  nutritional products.  They will assist us in choosing a few select
products  of  theirs  that they believe are their highest quality products, with
large  potential  markets,  and  with  profit  margins  that  would  warrant our
attention.


                                        9
<PAGE>

We  selected  Imagenetix, Inc. because they are established in the nutrition and
natural health product area.  If we were to lose this agreement with Imagenetix,
Inc., our ability to obtain a supply of quality product on favorable terms would
probably  be  greatly  hampered.  We believe that we would be able to find other
suppliers,  but that they would require a greater expenditure of management time
and  that  profit  margins  on  sales  may  decrease.

Our  websites  currently  list  two  products  for  sale.  Each  is  a  form  of
Imagenetix's  proprietary  product,  Celadrin(R).  We  market  a  cream  form of
Celadrin(R) in a jar and an oral capsules form of this product in a bottle.   We
place  a  label  on  each product sold identifying the product as either Vibrant
Creme  or  Vibrant Celcaps.  We have no exclusivity with respect to any of these
products.  In  fact,  there  are  several distributors that market other private
label forms of these products through their marketing organizations.  We are the
first  E-commerce  company  to  be  distributing  Celadrin(R).

Celadrin(R)  is  a  scientifically  tested  and  effective  formulated  product
developed  to  provide  support  for  healthy  joint  function  and  mobility.
Celadrin(R)  consists of a complex of scientifically targeted fatty acid esters.
The oral form of Celadrin(R) was subjected to clinical studies.   The results of
one  of  the  studies were published in the August, 2002 issue of The Journal of
Rheumatology.  We  intend  to  capitalize  on what we believe will be a surge of
demand  for  these products as new information is released on Celadrin(R) in the
near  future.

We  are  supplying  products under our own Vibrant Health brand name.  Imbedding
the  Vibrant Health name as part of the product title may significantly increase
the name recognition of both the product and the Company and assist the customer
to associate it with quality and value.  Costs associated with labeling products
with  our  name  are  minimal  and  consist  of  printing new labels for product
containers.


THREE  MONTH  PERIODS  ENDED  SEPTEMBER  30,  2002  AND  2001

The  Company had $15,791 in sales from continuing operations for the three month
period  ended September 30, 2002 and sales of $0 for the same three month period
in  2001.  Sales were higher in the quarter ended September 30, 2002 because the
Company didn't commence sales until the 4th quarter of 2001.  Cost of goods sold
was  $5,215  for the period ended September 30, 2002 compared to $0 for the same
period in 2001.   The Company had a gross profit of $10,576 for the three months
ended  September  30,  2002  compared  to  $0  for  the  same  period  in  2001.

Operating  expenses  for  the  three month periods ended September 30, 2002 were
$20,762  compared  to $3,908 for the same period in 2001.  Expenses consisted of
general  corporate  administration,  legal and professional expenses, accounting
and  auditing  costs,  and  wages.  Increased  expenses  for  the  period  ended
September  30,  2002  were  primarily  due  to costs associated with our initial
registration  statement.  The Company has interest expense of $842 for the three
months  ended  September  30,  2002  compared to $0 for the same period in 2001.

As a result of the foregoing factors, the Company realized a net loss of $11,028
for  the three months ended September 30, 2002 as compared to net loss of $3,908
for  the  same  period  in  2001.

NINE  MONTH  PERIODS  ENDED  SEPTEMBER  30,  2002  AND  2001

The  Company  had $19,604 in sales from continuing operations for the nine month
period  ended  September 30, 2002 and sales of $0 for the same nine month period
in  2001.  Sales were higher in the quarter ended September 30, 2002 because the
Company  didn't  begin  sales  until  4th quarter, 2001.  Cost of goods sold was


                                       10
<PAGE>

$6,575 for the nine month period ended September 30, 2002 compared to $0 for the
same  period  in  2001.   The Company had a gross profit of $13,029 for the nine
months  ended  September  30,  2002  compared to $0 for the same period in 2001.

Operating  expenses  for  the  nine  month  period ended September 30, 2002 were
$38,903  compared  to $3,944 for the same period in 2001.  Expenses consisted of
general  corporate  administration,  legal  and  professional  expenses,  and
accounting  and  auditing  costs  and  wages.  Increased expenses for the period
ended September 30, 2002 were primarily due to website development costs and the
costs  associated  with  our  initial  registration  statement.  The Company has
interest expense of $3,642 for the nine months ended September 30, 2002 compared
to  $0  for  the  same  period  in  2001.

As a result of the foregoing factors, the Company realized a net loss of $31,725
for  the  nine months ended September 30, 2002 as compared to net loss of $3,944
for  the  same  period  in  2001.

LIQUIDITY  AND  CAPITAL  RESOURCES

At  September 30, 2002 the Company had assets consisting of $7,520 cash on hand.
Current  liabilities  consisted  of  accounts  payable  and  accrued expenses of
$17,662,  a  note  payable  of  $25,000 and notes payable to a related party for
$15,000 for total current liabilities of $57,662.  The Company does not have any
long  term  capital  commitments.

The  Company  believes  that  its current cash needs can be met with the cash on
hand  and  from  the  proceeds  of its initial public offering whose proceeds of
$106,400  were  received  in  October.  However,  should  the  Company  find  it
necessary  to raise additional capital, the Company may sell common stock of the
Company  or  enter  into  debt  financing  agreements.

ITEM  3.  CONTROLS  AND  PROCEDURES

The Company, under the supervision of the chief executive and financial officer,
has  conducted an evaluation of the effectiveness of the design and operation of
the  Company's  disclosure  controls and procedures within 90 days of the filing
date  of  this quarterly report.  Based upon the results of this evaluation, the
Company  believes  that they maintain proper procedures for gathering, analyzing
and  disclosing  all  information  in  a  timely  fashion that is required to be
disclosed  in  its Exchange Act reports.  There have been no significant changes
in  the  Company's  controls  subsequent  to  the  evaluation  date.

PART  II:  OTHER  INFORMATION

ITEM  2.  CHANGES  IN  SECURITIES  AND  USE  OF  PROCEEDS

On  July  9, 2001, we issued 100,000 shares to our founder and President, Thomas
H. McAdam in exchange for $1,000 cash and we issued 2,109,000 shares in exchange
for  703,000  shares  of  Vibrant Health, Inc., and we issued 750,000 shares for
consideration  of  making  a loan of $15,000 accessible by the Company which was
valued  at  $750.  The  securities  were  sold  in private transactions, without
registration  in  reliance  on  the  exemption  provided  by Section 4(2) of the
Securities  Act.  The investor had access to all material information pertaining
to  the Company and its financial condition. The investor completed and signed a
subscription  agreement  attesting  to his sophistication or accredited investor
status  and  investment  intent.  No broker was involved and no commissions were
paid  in  the  transactions.

On July 9, 2001, we issued 801,000 shares to a shareholder in exchange for their
267,000  shares  of  Vibrant  Health,  Inc.  The  stock  was valued at $801. The
securities  were  sold in private transactions, without registration in reliance


                                       11
<PAGE>

on  the  exemption provided by Section 4(2) of the Securities Act. Each investor
had  access  to  all  material  information  pertaining  to  the Company and its
financial condition. Each investor completed and signed a subscription agreement
attesting  to  his  sophistication  or accredited investor status and investment
intent. No broker was involved and no commissions were paid in the transactions.

Mr.  Thomas McAdam thereafter purchased 550,000 shares of the newly issued stock
from  one  of  those  shareholders  in a private transaction, thus, bringing Mr.
Thomas  McAdam's  total ownership to 3,509,000 shares and reducing the other two
shareholders' total to a combined 251,000 shares.  The shares were purchased for
$550.00  on  August  27,  2001.

In  September  2001,  we issued 175,000 shares of common stock to two accredited
investors  for  a  total  of  $5,250.  The  securities  were  sold  in  private
transactions,  without  registration  in  reliance  on the exemption provided by
Section  4(2)  of  the  Securities Act. Each investor had access to all material
information pertaining to the Company and its financial condition. Each investor
completed and signed a subscription agreement attesting to his sophistication or
accredited  investor status and investment intent. No broker was involved and no
commissions  were  paid  in  the  transactions.

The  Company  filed  an  SB-2  Registration  Statement  with  the Securities and
Exchange  Commission  offering  a  minimum  of  350,000  shares and a maximum of
800,000  shares  at $0.25 per share.  The offering became effective on August 2,
2002  and  closed  on  October 22, 2002.  The Company successfully completed the
offering  of  425,600  shares  of  common  stock to 44 shareholders and received
proceeds  of  $106,400.  The  Company  incurred  expenses  in  the  amount  of
approximately  $24,000 relating to the Registration Statement.  Expenses include
legal  fees,  accounting  fees,  escrow fees, filing fees, printing and transfer
agent costs.  The Company also repaid loans of $40,000 together with interest of
$3,998.  There  were  no underwriters discounts, commissions or finders fees.  A
table  detailing the use of proceeds through November 8, 2002 is provided below.

<TABLE>
<CAPTION>

USE OF PROCEEDS                 AMOUNT
<S>                             <C>
Debt Repayment . . . . . . . .  $40,000
Interest on Loans. . . . . . .  $ 3,998
Legal Fees . . . . . . . . . .  $14,729
Accounting Fees. . . . . . . .  $ 7,750
Filing Fees. . . . . . . . . .  $ 1,140
Escrow and Transfer Agent Fees  $ 1,090
Website and Marketing. . . . .  $ 2,017
Various working capital items.  $   482

Total Proceeds Expended. . . .  $71,206

Balance of Proceeds Remaining.  $35,194
</TABLE>

ITEM  6.  EXHIBITS  AND  REPORTS  ON  FORM  8-K

Reports  on  Form  8-K:

     No  reports  on  Form 8-K were filed by Vibrant Health International during
the  three  months  ended  September  30,  2002.


                                       12
<PAGE>

<TABLE>
<CAPTION>

Exhibits:

EXHIBIT NUMBER  TITLE                                                                 LOCATION

<C>             <S>                                                                   <C>
          99.1    Certification of the Chief Executive Officer pursuant to 18 U.S.C.  Attached
                Section 1350, as adopted pursuant to Section 906 of the Sarbanes-
                Oxley Act of 2002

          99.2    Certification of the Chief Financial Officer pursuant to 18 U.S.C.  Attached
                Section 1350, as adopted pursuant to Section 906 of the Sarbanes-
                Oxley Act of 2002
</TABLE>



                                   SIGNATURES


Pursuant  to  the requirements of the Securities Exchange Act of 1934, this Form
10-QSB  Report,  for the quarter ended September 30, 2002, has been signed below
by  the  following person on behalf of the Registrant and in the capacity and on
the  date  indicated.


                                            VIBRANT  HEALTH  INTERNATIONAL


November  12,  2002                         /s/ Thomas  H.  McAdam
                                            -----------------------
                                            Thomas  H.  McAdam
                                            Chief  Executive  Officer  and
                                            Chief  Financial  Officer


                                       13
<PAGE>